Artivion, Inc.

NYSE:AORT

Medical - Devices

Healthcare
$18.54 -0.52%

-$0.11 today

Market cap
$904.56M
Beta
1.26
P/E (TTM)
86.7
EPS (TTM)
$0.24
52W Low $19.16High $48.25

Volume 0.91M

Average 0.64M

AORT Short-term Debt

Borrowings and the current portion of long-term debt due within one year.

Artivion, Inc.NYSE: AORT

Short-term Debt · Q1 FY2026 · quarter ended Mar 2026

Short-term debt rises 3995.6% from a year ago

Short-term debt stood at $5.53M at the end of Q1 FY2026, up 3995.6% from a year earlier and up 2.9% from the prior quarter. Over 3 fiscal years it compounded at +49.5% a year.

Context

  • Short-term debt amounted to 0.6% of total assets at the end of Q1 FY2026, up 0.6 pp from a year earlier.
  • Short-term debt increased in 1 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether short-term debt keeps rising in the next quarterly balance sheet after a +3995.6% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$5.53M+2.9% QoQ
Last fiscal yearDec 2025
$5.38M+2656.4% YoY
Year agoMar 2025
$135K+3995.6% since
Short-term Debt past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+3995.6%——
1 year+2656.4%——
3-year CAGR+49.5%——
5-year CAGR——
10-year CAGR——

Short-term Debt history

USD · from the balance sheet

Latest · FY2025
5.38M USD
Year-over-year change
+2656.4%
4-year CAGR
+34.8%

Short-term Debt vs competitors

How AORT compares with its peers on the latest reported figures

  • AORT's Mar 2026 short-term debt of $5.53M is the 6th highest of the 11 companies compared; the peer median is $4.85M.
  • Its year-over-year change of +3995.6% is the highest of 9, against a peer median of +12.5%.
  • Short-term debt amounts to 0.6% of total assets for AORT, versus a peer median of 0.2%.
AORT Competitors Peer median
Short-term Debt for AORT and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
BKDBrookdale Senior Living Inc.Sep 2026$138.41M +33.1%+32.4%2.3%
LFSTLifeStance Health Group, Inc.Jun 2026$46.5M +327.6%+168.8%2.1%
ARDTArdent Health Partners, LLCMar 2026$37.64M +111.9%-26.2%0.7%
SSIISS Innovations International, Inc.Mar 2026$11.73M +52.7%+24.4%13.0%
ITGRInteger Holdings CorporationJul 2026$8.21M -8.0%-9.3%0.2%
AORTArtivion, Inc.Mar 2026$5.53M +3995.6%+49.5%0.6%
COGTCogent Biosciences, Inc.Jun 2026$1.49M ——0.2%
LQDALiquidia CorporationJun 2026$0 -100.0%—0.0%
ADUSAddus HomeCare CorporationJun 2026$0 ——0.0%
INSPInspire Medical Systems, Inc.Jun 2026$0 -100.0%—0.0%
PRCTPROCEPT BioRobotics CorporationMar 2026$0 -100.0%—0.0%
Peer median (excluding AORT) $4.85M+12.5%+24.4%0.2%

Competitors are the stored peer set for AORT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents55.01M39.35M58.94M53.46M64.91M
Short-term Investments00000
Net Receivables58.11M69.58M74.14M85.89M103.68M
Inventory76.97M74.48M81.98M79.77M92.43M
Other Current Assets42.86M46.37M49.8M70.96M42.54M
Total Current Assets247.7M247.33M280.67M290.08M303.55M
Property, Plant & Equipment (Net)83.24M80.53M82.18M76.13M99.69M
Goodwill250M243.63M247.34M240.96M254.09M
Intangible Assets201.5M182.65M172.23M156.38M156.5M
Long-term Investments00000
Tax Assets2.36M1.31M1.09M1.07M1.2M
Other Non-current Assets8.27M7.34M8.89M24.48M69.77M
Total Non-current Assets545.36M515.46M511.73M499.02M581.25M
Total Assets793.05M762.8M792.4M789.1M884.8M
Account Payables10.4M12M13.32M17.97M16.04M
Short-term Debt1.63M1.61M1.45M195K5.38M
Tax Payables3.63M2.64M3.84M2.93M0
Deferred Revenue00000
Other Current Liabilities700K1.31M21.11M583K50.17M
Total Current Liabilities44.95M49.68M57.86M66.82M101.56M
Long-term Debt307.49M306.5M305.53M314.15M249.54M
Deferred Tax Liabilities28.8M24.5M21.85M20.18M24.31M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities61.84M52.9M77.99M68.92M24.03M
Total Non-current Liabilities447.37M428.79M452.76M446.08M335.01M
Total Liabilities492.32M478.47M510.62M512.9M436.56M
Common Stock414K418K426K434K493K
Retained Earnings1.98M(17.22M)(47.91M)(61.27M)(51.5M)
Accumulated OCI(9.89M)(21.61M)(12.01M)(24.93M)(2.72M)
Other Stockholders Equity00000
Minority Interest00000
Total Equity300.73M284.33M281.78M276.2M448.23M
Total Debt362.04M356.83M358.34M362.26M292.04M
Net Debt307.03M317.48M299.4M308.8M227.13M

Artivion, Inc.

NYSE:AORT

Intrinsic Alpha fair value

Locked

Current Price

$18.54

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.